Skip to main content
Caplight Logo









Trilliome

Trilliome

Private
ZurichHealthcare & Life Scienceshttps://trilliome.com/

Last Round

Accelerator

Nov 18, 2025

Total Funding Raised

$378,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Trilliome is a biotechnology company developing plant-derived, clinically validated ingredients that precisely modulate keystone gut microbial networks and their metabolites to target hallmarks of aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Circular Economy

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microbiome ingredientsgut-brain axisprecision prebioticsbioactive ingredientspsychobioticsgut healthcognitive health ingredientsnutraceutical ingredientsfunctional food ingredientsplant-derived ingredientslongevity ingredientsnootropic ingredientsGRASGenerally Recognized as Safeupcycled ingredientsbiotech consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trilliome Comparables

Compare Trilliome with similar companies based on industry and business-model similarity.

Trilliome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clasado Biosciences
77%
One Bio
71%
OptiBiotix Health Plc
69%

Trilliome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 18, 2025
GrantOct 17, 2025
GrantFeb 19, 2025
GrantNov 19, 2024

Key People

Founding team and executive leadership

Patrick Guye

CEO, Co-founder, Managing Partner

Founding Team

Christoph Schäfer

Fractional CFO

Executive Team

Trilliome Investors

Notable investors and investment history

Trilliome investors
InvestorRounds
Biotope by VIBAccelerator
EIT FoodGrant
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 18, 2025

    $270K raised from Biotope by VIB

  • Oct 17, 2025

    $53K grant received from EIT Food.

Trilliome Filings

Explore SEC and related filing metadata, where available.

Trilliome filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Trilliome's valuation, stock price, and market status.

Is Trilliome a public or private company?

Trilliome is a private company.

What is the current stock price of Trilliome?

Trilliome is a private company with no public stock price. No recent secondary market data is available.

How much is Trilliome worth (valuation)?

Valuation information for Trilliome is not publicly available.

Can I buy Trilliome stock?

Trilliome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Trilliome's last funding round?

Trilliome's most recent funding round was Accelerator on November 18, 2025.

Who are the main investors in Trilliome?

Key investors in Trilliome include Biotope by VIB.

Will Trilliome IPO soon?

No public IPO plans have been announced for Trilliome.

How can I track Trilliome secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trilliome's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZurich
Employee Range5
Year Founded2023
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?